Nabilona (Portuguese Wikipedia)
Analysis of information sources in references of the Wikipedia article "Nabilona" in Portuguese language version.
refsWebsite
Global rank
Portuguese rank
low place
low place
274th place
339th place
low place
low place
low place
low place
doi.org
dx.doi.org
- Fine PG, Rosenfeld MJ (2013). «The endocannabinoid system, cannabinoids, and pain». Rambam Maimonides Medical Journal (Review). 4: e0022. PMC 3820295
. PMID 24228165. doi:10.5041/RMMJ.10129 - Wissel J, Haydn T, Müller J, Brenneis C, Berger T, Poewe W, Schelosky LD. «Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial». Journal of Neurology (Research article). 253: 1337–41. PMID 16988792. doi:10.1007/s00415-006-0218-8
- Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, Buckley N, Farrell M. «The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews». Current Neurology and Neuroscience Reports. 18. 8 páginas. PMID 29442178. doi:10.1007/s11910-018-0814-x
- Lynch ME, Campbell F. «Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials». British Journal of Clinical Pharmacology. 72: 735–44. PMC 3243008. PMID 21426373. doi:10.1111/j.1365-2125.2011.03970.x
- Bedi G, Cooper ZD, Haney M. «Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers». Addiction Biology. 18: 872–81. PMC 3335956. PMID 22260337. doi:10.1111/j.1369-1600.2011.00427.x
- Cunningham D, Bradley CJ, Forrest GJ, Hutcheon AW, Adams L, Sneddon M, Harding M, Kerr DJ, Soukop M, Kaye SB. «A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues». European Journal of Cancer & Clinical Oncology (Randomized controlled trial). 24: 685–9. PMID 2838294. doi:10.1016/0277-5379(88)90300-8
- Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S. «Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy». The Cochrane Database of Systematic Reviews: CD009464. PMC 6931414. PMID 26561338. doi:10.1002/14651858.CD009464.pub2
- Pini LA, Guerzoni S, Cainazzo MM, Ferrari A, Sarchielli P, Tiraferri I, Ciccarese M, Zappaterra M. «Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial». The Journal of Headache and Pain. 13: 677–84. PMC 3484259. PMID 23070400. doi:10.1007/s10194-012-0490-1
medicalmarijuana.eu
- «Cannabis Laws & Scheduling in Europe - MedicalMarijuana.eu». MedicalMarijuana.eu. Consultado em 17 de novembro de 2016
nih.gov
ncbi.nlm.nih.gov
- Fine PG, Rosenfeld MJ (2013). «The endocannabinoid system, cannabinoids, and pain». Rambam Maimonides Medical Journal (Review). 4: e0022. PMC 3820295. PMID 24228165. doi:10.5041/RMMJ.10129
- Wissel J, Haydn T, Müller J, Brenneis C, Berger T, Poewe W, Schelosky LD. «Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial». Journal of Neurology (Research article). 253: 1337–41. PMID 16988792. doi:10.1007/s00415-006-0218-8
- Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, Buckley N, Farrell M. «The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews». Current Neurology and Neuroscience Reports. 18. 8 páginas. PMID 29442178. doi:10.1007/s11910-018-0814-x
- Lynch ME, Campbell F. «Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials». British Journal of Clinical Pharmacology. 72: 735–44. PMC 3243008. PMID 21426373. doi:10.1111/j.1365-2125.2011.03970.x
- Bedi G, Cooper ZD, Haney M. «Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers». Addiction Biology. 18: 872–81. PMC 3335956. PMID 22260337. doi:10.1111/j.1369-1600.2011.00427.x
- Cunningham D, Bradley CJ, Forrest GJ, Hutcheon AW, Adams L, Sneddon M, Harding M, Kerr DJ, Soukop M, Kaye SB. «A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues». European Journal of Cancer & Clinical Oncology (Randomized controlled trial). 24: 685–9. PMID 2838294. doi:10.1016/0277-5379(88)90300-8
- Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S. «Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy». The Cochrane Database of Systematic Reviews: CD009464. PMC 6931414. PMID 26561338. doi:10.1002/14651858.CD009464.pub2
- «Long-term Nabilone Use: A Review of the Clinical Effectiveness and Safety». CADTH Rapid Response Reports. PMID 26561692
- Pini LA, Guerzoni S, Cainazzo MM, Ferrari A, Sarchielli P, Tiraferri I, Ciccarese M, Zappaterra M. «Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial». The Journal of Headache and Pain. 13: 677–84. PMC 3484259. PMID 23070400. doi:10.1007/s10194-012-0490-1
pharmatimes.com
- «Valeant returns synthetic cannabinoid to USA». Pharma Times (em inglês). 17 de maio de 2006
- «FDA turns down Valeant's anti-nausea drug». Pharma Times (em inglês). 3 de janeiro de 2006
thepharmaletter.com
- «Cambridge Labs divests nabilone to Valeant - Pharmaceutical industry n». The Pharma Letter. 27 de fevereiro de 2007